Enliven Therapeutics Inc (ELVN)
Operating Cash Flow Growth
5.16%
TTM · Period ending:
ELVN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported5.16%period ending
Latest reported5.16%period ending
ELVN TTM Cash from Operations YoY % (-70.95% → 5.16%)
Year-over-year change
High-resolution chart · PNG
ELVN operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 5.1587% | |
| 11.4835% | |
| 3.9499% | |
| -4.6662% | |
| 2.2058% | |
| -15.9471% | |
| -19.4601% | |
| -20.268% | |
| -51.989% | |
| -49.8731% | |
| -91.006% | |
| -56.3336% | |
| -16.1826% | |
| 3.5183% | |
| 31.4169% | |
| 14.4237% | |
| 2.6881% | |
| -7.877% | |
| -25.0628% | |
| -14.4844% | |
| -26.8691% | |
| -41.018% | |
| -70.9467% |